Highdose Chemotherapy and Transplantation of 34+ Selected Stem Cell for Progressive Systemic Sclerosis - Modification According to Manifestation (AST MOMA)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2013 by University Hospital Tuebingen
Sponsor:
Information provided by (Responsible Party):
Joerg Henes, University Hospital Tuebingen
ClinicalTrials.gov Identifier:
NCT01895244
First received: July 1, 2013
Last updated: July 11, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2020
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)
No publications provided by University Hospital Tuebingen

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):